Analytik Jena AG
Analytik Jena announces performance adjustment for the financial year 04/05
Ad hoc announcement §15 WpHG
Performance adjustment
Analytik Jena announces performance adjustment for the financial year 04/05
Ad hoc announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————
Jena, July 7, 2005 – Despite an upturn in the last quarter, Analytik Jena
will be unable to reach the Group’s original planned figures. Instead of the
previously planned figure of > EUR 2.0 million in EBIT, the company now
anticipates approx. EUR 0.5 million with sales of around EUR 68 million.
Reasons for this are:
– In the project business, the realisation of key major projects has been
postponed until the next financial year as a result of delayed funding
approval from the customers. This results in a pro rata reduction of sales and
results in the current year.
– The results of two affiliates from the instruments business are impacted by
non-recurring effects. Due to the threatened insolvency of a customer, at one
company orders had to be cancelled that were scheduled to be realised during
this financial year and accounted for approx. 25% of the year’s sales. In the
second case, decisions taken by operational management led to high losses at
the subsidiary. Group management instituted the necessary restructuring
measures for both companies immediately and implemented changes to their
management bodies in this connection. The Management Board anticipates that it
will already be possible to lead these companies back into the black next
financial year.
Irrespective of these facts, it must be added that the achievement of the
targets for 2004/2005 was already considered very ambitious – although not
unrealistic – at the half-year stage. The planning for the current financial
year was based on a stable project business and on the instruments business
strengthening in the second half of the year.
Whilst major projects have been postponed in the project business, the core
business in the “Instruments” division – with the Analytik Jena AG business
units analytical and bioanalytical solutions – has developed as forecast.
Since February this year, Analytik Jena has posted significantly higher
incoming orders in comparison to the previous year in both business units. At
the start of the second half of the year, the products newly launched on the
market are also contributing to the increase in incoming orders.
In connection with the measures implemented, the Board of Directors
anticipates that the Group will successfully continue to realise its strategic
objectives.
The date scheduled for the publication of the nine-months-report is August 5,
2005.
Contact: Analytik Jena AG | Thomas Fritsche | Investor Relations |
Konrad Zuse Str. 1 | D- 07745 Jena | Germany | Voice: +49 (0)3641 / 77 –
92 81 | Fax: +49 (0)3641 / 77 – 99 88 | Mobil: +49 (0)176 / 1 7777 005 |
E-mail: t.fritsche@analytik-jena.de | Internet: http://www.analytik-jena.de
Analytik Jena AG
Konrad-Zuse-Straße 1
07745 Jena
Deutschland
ISIN: DE0005213508
WKN: 521350
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin-
Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart
End of ad hoc announcement (c)DGAP 07.07.2005
070816 Jul 05
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden